Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK
Authors:
- Xin SunXSXin Sun
- Heng MaHMHeng Ma
- Hai-Feng ZhangHZHai-Feng Zhang
- Qiu-Jun YuQYQiu-Jun Yu
- Chen HuangCHChen Huang
- Xiao-Ming WangXWXiao-Ming Wang
- Rong-Hua LuanRLRong-Hua Luan
- Guo-Liang JiaGJGuo-Liang Jia
- Hai-Chang WangHWHai-Chang Wang
- Feng GaoFeng Gao
Open Access
- 1 September 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 293 (3) , E629-E635
Abstract
There is a close association between hyperglycemia and increased risk of mortality after acute myocardial infarction (AMI). However, whether acute hyperglycemia exacerbates myocardial ischemia/reperfusion (MI/R) injury remains unclear. We observed the effects of acute hyperglycemia on MI/R injury and on the cardioprotective effect of glucose-insulin-potassium (GIK). Male rats were subjected to 30 min of myocardial ischemia and 6 h of reperfusion. Rats were randomly received one of the following treatments (at 4 ml·kg−1·h−1 iv): Vehicle, GIK (GIK during reperfusion; glucose: 200g/l, insulin: 60 U/l, KCL: 60 mmol/l), HG (high glucose during ischemia; glucose:500 g/l), GIK + HG (HG during I and GIK during R) or GIK + wortmannin (GIK during R and wortmannin 15 min before R). Blood glucose, plasma insulin concentration and left ventricular pressure (LVP) were monitored throughout the experiments. Hyperglycemia during ischemia not only significantly increased myocardial apoptosis (23.6 ± 1.7% vs. 18.8 ± 1.4%, P < 0.05 vs. vehicle), increased infarct size (IS) (45.6 ± 3.0% vs. 37.6 ± 2.0%, P < 0.05 vs. vehicle), decreased Akt and GSK-3β phosphorylations (0.5 ± 0.2 and 0.6 ± 0.1% fold of vehicle, respectively, P < 0.05 vs. vehicle) following MI/R, but almost completely blocked the cardioprotective effect afforded by GIK, as evidenced by significantly increased apoptotic index (19.1 ± 2.0 vs. 10.3 ± 1.2%, P < 0.01 vs. GIK), increased myocardial IS (39.2 ± 2.8 vs. 27.2 ± 2.1%, P < 0.01 vs. GIK), decreased Akt phosphorylation (1.1 ± 0.1 vs. 1.7 ± 0.2%, P < 0.01 vs. GIK) and GSK-3β phosphorylation (1.4 ± 0.2 vs. 2.3 ± 0.2%, P < 0.05 vs. GIK). Hyperglycemia significantly exacerbates MI/R injury and blocks the cardioprotective effect afforded by GIK, which is, at least in part, due to hyperglycemia-induced decrease of myocardial Akt activation.Keywords
This publication has 27 references indexed in Scilit:
- Physiologically Tolerable Insulin Reduces Myocardial Injury and Improves Cardiac Functional Recovery in Myocardial Ischemic/Reperfused DogsJournal of Cardiovascular Pharmacology, 2006
- Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats1Acta Pharmacologica Sinica, 2005
- Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityEuropean Heart Journal, 2005
- Fasting Glucose Is an Important Independent Risk Factor for 30-Day Mortality in Patients With Acute Myocardial InfarctionCirculation, 2005
- Acute hyperglycaemia: a ‘new’ risk factor during myocardial infarctionEuropean Heart Journal, 2004
- Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in ratsJournal of Molecular and Cellular Cardiology, 2004
- Prognostic value of admission glucose in non-diabetic patients with myocardial infarctionAmerican Heart Journal, 2004
- Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase ComplexJournal of Biological Chemistry, 2002
- Nitric Oxide Mediates the Antiapoptotic Effect of Insulin in Myocardial Ischemia-ReperfusionCirculation, 2002
- p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulationCardiovascular Research, 2002